Meng-Ju Wu to Biliary Tract Neoplasms
This is a "connection" page, showing publications Meng-Ju Wu has written about Biliary Tract Neoplasms.
Connection Strength
0.471
-
Lin YY, Kuo HH, He ZJ, Chung HY, Kim CH, Pan YR, Wu MJ, Chan MH, Yeh CN, Chiang NJ, Chen MH, Chang YC. SLC25A11-mediated reprogramming of mitochondrial redox state and lipid peroxidation confers NRF2-dependent ferroptosis resistance in biliary tract cancer. Cell Mol Biol Lett. 2026 Jan 09; 31(1).
Score: 0.238
-
Vijay V, Karisani N, Shi L, Hung YH, Vu P, Kattel P, Kenney L, Merritt J, Adil R, Wu Q, Zhen Y, Morris R, Kreuzer J, Kathiresan M, Herrera Lopez XI, Ellis H, Gritti I, Lecorgne L, Farag I, Popa A, Shen W, Kato H, Xu Q, Balasooriya ER, Wu MJ, Wan J, Kondo H, Chaturantabut S, Raghavan S, Hall MD, Patnaik S, Shen M, Kelley RK, Cleary JM, Lawrence MS, Root DE, Patra KC, Silveira VS, Benes CH, Deshpande V, Juric D, Sellers WR, Ferrone CR, Haas W, Vazquez F, Getz G, Bardeesy N. Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets. Cancer Discov. 2025 Sep 04; 15(9):1858-1882.
Score: 0.232